Emerging biotech stocks typically are one-trick ponies which is one major reason why the likelihood of success is elusive and rare.

Yesterday’s landmark announcement by Nuvilex Inc. (OTCQB – NVLX) likely assures that the company will receive a future boost in its overall valuation. Nuvilex has acquired the exclusive worldwide rights to use the cellulose-based live-cell encapsulation technology for the development of treatments for diabetes from SG Austria Pte. Ltd.

In a year where there have been quite a few misfires in the small biotech world, Nuvilex, Inc. (OTCQB – NVLX - $0.139 – Spec Buy) is a shining star.

According to a recent report released by global technology research firm ON World, demand for health and fitness solutions has spurred widespread adoption of mobile sensing health and fitness devices.

We believe ERNI will experience exponential membership and revenue growth over the coming quarters as it penetrates its current target markets during Q4, typically the industry’s most important season. As a result, we rate what may be the only pure play membership rewards stock Speculative Buy with a $1.05 price target.

In a move that we believe will add meaningful value to the overall company, Plandaí¬ Biotechnology, Inc. (OTCQB – PLPL - $0.51 – Spec Buy) recently announced that it has formed a new wholly-owned subsidiary, Cannabis Biosciences, Inc., to develop and test a new Phytofare™ botanical extract derived from cannabis.

Savvy traders and followers of Nuvilex, Inc. (OTCQB – NVLX - $0.114 – Spec Buy), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases can sense that a return to much higher levels is brewing.

Much like in the 1970’s and 1980’s when growth in the popularity of tennis was driven by major names such as Jimmy Conners, John McEnroe, Ivan Lendl, and Martina Navratilova, history is repeating itself.

Laredo Resources, Inc.appears to be on the verge of cashing in on some of the material found on the patented claims on its site in southwestern Montana, which would have a major positive impact on the value of the company’s stock.